Trial Profile
Bioequivalence of Fixed-Dose Combinations of Dapagliflozin/Metformin Relative to Single Components in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Dapagliflozin/metformin (Primary) ; Dapagliflozin; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 09 Dec 2015 Results published in the Clinical Therapeutics
- 29 Oct 2015 New trial record